Table 6 Correlation between PD-1/PD-L1 status in metastatic lymph node (LN) and clinicopathological characteristics.
 | PD-1(LN) | PD-L1(LN) | |
---|---|---|---|
ER(MLN) | r | 0.39 | 0.25 |
p | 0.724 | 0.630 | |
PR(MLN) | r | 1.21 | 0.23 |
p | 0.403 | 0.766 | |
HER-2(MLN) | r | 0.55 | 0.85 |
p | 0.561 | 0.436 | |
EGFR(MLN) | r | 1.33 | 0.002 |
p | 0.416 | 1.000 | |
Ki-67(MLN) | r | 3.53 | 4.36 |
p | 0.082 | 0.048* | |
Age | r | 0.18 | 4.35 |
p | 0.773 | 0.046* | |
TNM stage | r | 0.17 | 6.50 |
P | 0.772 | 0.012* | |
Histology grade | r | 5.87 | 0.92 |
p | 0.029* | 0.428 | |
Metastatic LN number | r | 0.43 | 8.92 |
p | 0.524 | 0.002* | |
LVI | r | 1.21 | 0.12 |
p | 0.318 | 1.000 |